Identification of Amino Acid Residues Important for Ligand Binding to Fas

por Starling, Gary C., Bajorath, Jürgen, Emswiler, John, Ledbetter, Jeffrey A., Aruffo, Alejandro, Kiener, Peter A.
Publicado 1997

Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse...

por Mejías, Asunción, Chávez-Bueno, Susana, Raynor, Martin B, Connolly, John, Kiener, Peter A, Jafri, Hasan S, Ramilo, Octavio
Publicado 2007

Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and Macrophages

por Kiener, Peter A., Davis, Patricia M., Starling, Gary C., Mehlin, Christopher, Klebanoff, Seymour J., Ledbetter, Jeffrey A., Liles, W. Conrad
Publicado 1997

Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus

por Ulbrandt, Nancy D., Ji, Hong, Patel, Nita K., Barnes, Arnita S., Wilson, Susan, Kiener, Peter A., Suzich, JoAnn, McCarthy, Michael P.
Publicado 2008

Type I Interferon: Potential Therapeutic Target for Psoriasis?

por Yao, Yihong, Richman, Laura, Morehouse, Chris, de los Reyes, Melissa, Higgs, Brandon W., Boutrin, Anmarie, White, Barbara, Coyle, Anthony, Krueger, James, Kiener, Peter A., Jallal, Bahija
Publicado 2008

Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?

por Yao, Yihong, Richman, Laura, Morehouse, Chris, de los Reyes, Melissa, Higgs, Brandon W., Boutrin, Anmarie, White, Barbara, Coyle, Anthony, Krueger, James, Kiener, Peter A., Jallal, Bahija
Publicado 2009

Respiratory Syncytial Virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice

por Torres, Juan Pablo, Gomez, Ana M, Khokhar, Shama, Bhoj, Vijay G, Tagliabue, Claudia, Chang, Michael L, Kiener, Peter A, Revell, Paula A, Ramilo, Octavio, Mejias, Asuncion
Publicado 2010

Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus

por Yao, Yihong, Higgs, Brandon W., Morehouse, Chris, de los Reyes, Melissa, Trigona, Wendy, Brohawn, Philip, White, Wendy, Zhang, Jianliang, White, Barbara, Coyle, Anthony J., Kiener, Peter A., Jallal, Bahija
Publicado 2009

Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells

por Seidel, Ronald D., Merazga, Zohra, Thapa, Dharma Raj, Soriano, Jonathan, Spaulding, Emily, Vakkasoglu, Ahmet S., Ruthardt, Paige, Bautista, Wynona, Quayle, Steven N., Kiener, Peter A., Low, Simon, Ross, John F., Cemerski, Saso, Suri, Anish, Almo, Steven C., Chaparro, Rodolfo J.
Publicado 2021

Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis

por Kanakaraj, Palanisamy, Puffer, Bridget A., Yao, Xiao-Tao, Kankanala, Spandana, Boyd, Ernest, Shah, Rutul R., Wang, Geping, Patel, Dimki, Krishnamurthy, Rajesh, Kaithamana, Shashi, Smith, Rodger G., LaFleur, David W., Barbas III, Carlos F., Hilbert, David M., Kiener, Peter A., Roschke, Viktor V.
Publicado 2012

Monoclonal antibody therapeutics with up to five specificities: Functional enhancement through fusion of target-specific peptides

por LaFleur, David W., Abramyan, Donara, Kanakaraj, Palanisamy, Smith, Rodger G., Shah, Rutul R., Wang, Geping, Yao, Xiao-Tao, Kankanala, Spandana, Boyd, Ernie, Zaritskaya, Liubov, Nam, Viktoriya, Puffer, Bridget A., Buasen, Pete, Kaithamana, Shashi, Burnette, Andrew F., Krishnamurthy, Rajesh, Patel, Dimki, Roschke, Viktor V., Kiener, Peter A., Hilbert, David M., Barbas III, Carlos F.
Publicado 2013